Balchem : Announces Quarterly Conference Call for Second Quarter Financial Results on August 4, 2017
July 25, 2017 at 06:35 pm EDT
Share
New Hampton, New York. July 25, 2017. Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, August 4, 2017 at 11:00 AM Eastern Time (ET) to review second quarter 2017 results. Ted Harris, Chairman of the Board, CEO and President, and Bill Backus, Chief Financial Officer, will host the call.
Second quarter results will be published prior to the market opening on Friday, August 4, 2017. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call.
We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for replay two hours after the conclusion of the call through end of day Friday, August 18, 2017. To access the replay of the conference call, dial 1-877-660-6853 (local dial-in 1-201-612-7415), and use conference ID #13667775.
About Balchem Corporation
Balchem Corporation reports four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications.
Balchem Corporation published this content on 25 July 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 25 July 2017 22:35:05 UTC.
Original documenthttp://www.balchem.com/balchem-corporation-announces-quarterly-conference-call-second-quarter-financial-results-august-4-0
Public permalinkhttp://www.publicnow.com/view/5A6EE1EF9DAF0B134DC786162F9B1172B78B27D4
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.